HPGD and colorectal carcinoma: 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is the key enzyme in PGE2 catabolism and is often downregulated in CRC, while its upregulation has been shown to lead to a better prognosis in CRC (20–22).